AQUESTIVE THERAPEUTICS INC
(NASDAQ: AQST)

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

4.260

+0.160 (+3.90%)
Range - - -   (-%)
Open 4.270
Previous Close 4.100
Bid Price 2.380
Bid Volume 30
Ask Price 2.390
Ask Volume 11
Volume 7,207,766
Value -
Remark
Delayed prices. Updated at 29 Mar 2024 04:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis